15 November 2023
15 November 2023
NHS chief executive Amanda Pritchard says vaccination and screening could make eliminating cervical cancer a reality in the next two decades.
At BIO-Europe 2023, experts highlighted challenges in fundraising and concerns about impending EU legislative changes.
The co-morbidities space in the obesity market is becoming increasingly competitive, with products from both Lilly and Novo Nordisk.
Currently, there are four FDA-approved innovator drugs for this condition, all of which are Janus kinase (JAK) inhibitors.
Jazz will be responsible for clinical development, production, regulatory works and marketing.
Telix with pay $2m upfront, $33m on closing, and up to $90m in milestone-based payments.
The latest funding takes the investments secured by MBrace to a total of $110m.
The company intends to use the funds to advance its cancer vaccine clinical pipeline, including a colorectal cancer vaccine.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
As PD therapy currently centers on symptomatic treatment, the need for DMTs is one of the greatest unmet needs. Several companies within the late-stage PD pipeline are developing drugs that target PD via novel MOAs. Targeting α-synuclein and other neurotoxic proteins is a key strategy in the late-stage pipeline for DMTs. However, the lack of validated predictive biomarkers of PD progression have made the development of DMTs and neuroprotective agents challenging.
Give your business an edge with our leading industry insights.
